Augmedics announced today that it appointed a new independent director to its board and a new chief marketing officer. Chicago-based Augmedics confirmed that Nadav Tomer will join as an independent director, while Reed Krider will be chief marketing officer (CMO). Tomer joins with 23 years of global experience, having retired from Johnson & Johnson in […]
augmedics
Former Bardy Diagnostics CEO assumes corner office at Augmedics
Augmedics announced that it appointed former Bardy Diagnostics CEO Kevin Hykes as its new president & CEO. A 30-year medical device veteran, Hykes previously served as an operating partner at Revival Healthcare Capital. Before that, he was president & CEO at Bardy Diagnostics, having held the same roles at Relievant Medsystems. Additionally, Hykes has been […]
Augmedics appoints chief financial officer
Augmedics announced today that it appointed Raj Asarpota as its new EVP and CFO. Chicago-based Augmedics said in a news release that Asarpota, whose role becomes effective today, will lead the company’s global finance organization and be responsible for accounting, treasury, financial planning and analysis, tax and investor relations. The augmented reality-based imaging technology developer […]
MedTech 100 roundup: Industry continues climb
One week after hitting an all-time best mark, the medtech industry has done it again, reaching new heights on Wall Street. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — continued its rise, finishing the week (July 9) at 114.79 points, a rise of 0.2% from the 114.59-point mark […]
Augmedics adds J&J, Stryker veterans to board leadership
Augmedics announced that it appointed Rick Anderson as executive chairman of its board and Bradley Paddock as the board’s independent director. Chicago-based Augmedics said yesterday in a news release that Anderson joined the board in March upon the closing of Augmedics’ oversubscribed $36 million Series C financing round. Paddock then joined in May and both […]
Augmedics raises $36M in oversubscribed Series C
Augmented reality-based imaging company Augmedics announced that it raised $36 million in an oversubscribed Series C financing round. Having closed a $21 million Series B round eight months ago, Chicago-based Augmedics has raised $63 million to date, according to a news release. The company plans to use the funds to continue commercialization efforts, develop the […]
20 medical device startups you need to know
The medtech industry isn’t immune from COVID-19 troubles, but exciting innovation continues. These 20 medical device startups have grabbed our attention. Tom Salemi, DeviceTalks Editorial Director and Sean Whooley, Assistant Editor A number of medical device startups continue to make waves across the space, with new technologies and eye-watering fundraising rounds highlighting some exciting prospects. […]
Augmedics launches its Xvision Spine AR nav system in U.S.
Augmedics announced today that it won FDA 510(k) clearance for and initiated the U.S. launch of its Xvision Spine augmented reality guidance system to be used in surgery. The company is touting Xvision Spine as the first AR guidance system to be used in surgery. The system is designed to allow surgeons to visualize the […]
Augmedics launches first-in-human Xvision-spine AR nav system trial
Surgical VR developer Augmedics said last week it began the first-in-human clinical trial of its Xvision-spine augmented reality surgical navigation center. The trial was launched at at Israel’s Sheba Tel Hashomer Medical Center and Asaf Harofeh Medical Center, led by co-principal investigators Dr. Ran Harel and Dr. Yigal Mirovsky. The Xvision-spine system is an AR surgical navigation […]
Surgical VR dev Augmedics raises $8m in Series A
Surgical VR developer Augmedics said today it raised $8.3 million in a Series A funding round to support its ViZOR system. The round was led by Davos, AO Invest, the Israeli Innovation Authority, Terra Venture Partners and other undisclosed investors, the Israel-based company said. Proceeds from the round will support continued R&D, pre-clinical trials of […]
